Department of Psychological and Brain Sciences, Indiana University-Bloomington, Bloomington, IN, USA.
Neuropsychobiology. 2017;75(2):53-62. doi: 10.1159/000480511. Epub 2017 Oct 24.
BACKGROUND/AIMS: The onset response to a single tone as measured by electroencephalography (EEG) is diminished in power and synchrony in schizophrenia. Because neural synchrony, particularly at gamma frequencies (30-80 Hz), is hypothesized to be supported by the N-methyl-D-aspartate receptor (NMDAr) system, we tested whether phencyclidine (PCP), an NMDAr antagonist, produced similar deficits to tone stimuli in rats.
Experiment 1 tested the effect of a PCP dose (1.0, 2.5, and 4.5 mg/kg) on response to single tones on intracranial EEG recorded over the auditory cortex in rats. Experiment 2 evaluated the effect of PCP after acute administration of saline or PCP (5 mg/kg), after continuous subchronic administration of saline or PCP (5 mg/kg/day), and after a week of drug cessation. In both experiments, a time-frequency analysis quantified mean power (MP) and phase locking factor (PLF) between 1 and 80 Hz. Event-related potentials (ERPs) were also measured to tones, and EEG spectral power in the absence of auditory stimuli.
Acute PCP increased PLF and MP between 10 and 30 Hz, while decreasing MP and PLF between approximately 50 and 70 Hz. Acute PCP produced a dose-dependent broad-band increase in EEG power that extended into gamma range frequencies. There were no consistent effects of subchronic administration on gamma range activity. Acute PCP increased ERP amplitudes for the P16 and N70 components.
Findings suggest that acute PCP-induced NMDAr hypofunction has differential effects on neural power and synchrony which vary with dose, time course of administration and EEG frequency. EEG synchrony and power appear to be sensitive translational biomarkers for disrupted NMDAr function, which may contribute to the pathophysiology of schizophrenia and other neuropsychiatric disorders.
背景/目的:脑电图(EEG)测量的单个音调的起始反应在精神分裂症中功率和同步性降低。由于神经同步性,特别是在伽马频率(30-80 Hz)下,被假设由 N-甲基-D-天冬氨酸受体(NMDAr)系统支持,我们测试了苯环利定(PCP),一种 NMDAr 拮抗剂,是否在大鼠对音调刺激产生类似的缺陷。
实验 1 测试了 PCP 剂量(1.0、2.5 和 4.5 mg/kg)对大鼠听觉皮层颅内 EEG 记录的单个音调反应的影响。实验 2 评估了急性给予盐水或 PCP(5 mg/kg)后、连续亚慢性给予盐水或 PCP(5 mg/kg/天)后以及停药一周后 PCP 的作用。在这两个实验中,时间-频率分析量化了 1 到 80 Hz 之间的平均功率(MP)和相位锁定因子(PLF)。还测量了对音调的事件相关电位(ERP)和无听觉刺激时的 EEG 光谱功率。
急性 PCP 增加了 10 到 30 Hz 之间的 PLF 和 MP,而大约 50 到 70 Hz 之间的 MP 和 PLF 则降低了。急性 PCP 产生了与剂量相关的宽带增加,扩展到伽马频带频率的 EEG 功率。亚慢性给药对伽马频带活动没有一致的影响。急性 PCP 增加了 P16 和 N70 成分的 ERP 幅度。
研究结果表明,急性 PCP 诱导的 NMDAr 功能低下对神经功率和同步性具有不同的影响,这些影响随剂量、给药时间过程和 EEG 频率而变化。EEG 同步性和功率似乎是 NMDAr 功能障碍的敏感转化生物标志物,这可能有助于精神分裂症和其他神经精神疾病的病理生理学。